Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1990-10-2
|
pubmed:abstractText |
EIA was used to demonstrate that the development of acute ischemia of the heart muscle progressing to necrosis is accompanied by an increase of the concentration of cytochrome c and antibodies against cytochrome c in the blood serum. As regards its specificity and sensitivity, the alteration in the antibody concentration is comparable with that in the myoglobin concentration but it is marked 1 to 3 hours earlier. The high level of antibodies against cytochrome c remaining unchanged for 2 to 3 days in myocardial infarction patients attests to the possibility of a complicated, often relapsing course of the disease. The test for determining antibodies against cytochrome c may be recommended for the control over the patient's status and forecasting the course of myocardial infarction.
|
pubmed:language |
rus
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0040-3660
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
62
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
58-61
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2168094-Antibodies,
pubmed-meshheading:2168094-Chronic Disease,
pubmed-meshheading:2168094-Coronary Disease,
pubmed-meshheading:2168094-Cytochrome c Group,
pubmed-meshheading:2168094-Humans,
pubmed-meshheading:2168094-Immunoenzyme Techniques,
pubmed-meshheading:2168094-Myocardial Infarction,
pubmed-meshheading:2168094-Prognosis,
pubmed-meshheading:2168094-Time Factors
|
pubmed:year |
1990
|
pubmed:articleTitle |
[Determination of the concentration of cytochrome c and its antibodies in the blood serum for the diagnosis and prognosis of complications in myocardial infarct patients].
|
pubmed:publicationType |
Journal Article,
Comparative Study,
English Abstract
|